semaxinib and Acquired-Immunodeficiency-Syndrome

semaxinib has been researched along with Acquired-Immunodeficiency-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for semaxinib and Acquired-Immunodeficiency-Syndrome

ArticleYear
Fatal hepatorenal failure and thrombocytopenia with SU5416, a vascular endothelial growth factor Flk-1 receptor inhibitor, in AIDS-Kaposi's sarcoma.
    AIDS (London, England), 2007, Jan-02, Volume: 21, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Angiogenesis Inhibitors; Fatal Outcome; Humans; Indoles; Liver Failure; Male; Middle Aged; Pyrroles; Renal Insufficiency; Sarcoma, Kaposi; Skin Neoplasms

2007
KS trial begins.
    AIDS patient care and STDs, 2000, Volume: 14, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Angiogenesis Inhibitors; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Indoles; Male; Multicenter Studies as Topic; Patient Selection; Pyrroles; Sarcoma, Kaposi; United States

2000